Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
The demise of a controversial tax inversion deal with Allergan may have frustrated Pfizer, but it doesn't leave the U.S. drug giant that much poorer.
April 06, 2016 at 08:27 PM
1 minute read
The original version of this story was published on The American Lawyer
Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS